Calciject 40 CM Solution for Injection
Boric Acid, Calcium, Magnesium
Last verified
Veterinary medicinal product: solution for injection. Distribution category: POM-VPS (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Boric Acid, Calcium, Magnesium.1
In short: questions and answers
- Does Calciject 40 CM Solution for Injection need a prescription?
- Status not established. Neither the leaflet nor the law settles how this drug is dispensed, and we do not guess.
- Which animals is Calciject 40 CM Solution for Injection for?
- Cattle.1
- What is the active substance in Calciject 40 CM Solution for Injection?
- Boric Acid, Calcium, Magnesium. ATCvet code: QA12AX.13
- What is the withdrawal period of Calciject 40 CM Solution for Injection according to the leaflet?
- Cattle, meat: 0 days; Cattle, milk: 0 days.3
- Dispensing
- Status not established
POM-VPS: Prescription Only Medicine - Veterinarian, Pharmacist, Suitably Qualified Person. Prescription only, but the prescription may come from a veterinary surgeon, a pharmacist or a suitably qualified person (SQP, a registered animal-medicine adviser), and they may supply it.12
- Animal species
- Cattle1
- Active substance
- Boric Acid, Calcium, Magnesium
- ATCvet code
- QA12AX3
- Manufacturer
- Marketing authorisation holder: Norbrook Laboratories Limited
Withdrawal period
Summary of product characteristics
Composition
Active Substance:
| Contains Calcium Borogluconate | 40% w/v |
|---|---|
| Magnesium Hypophosphite Hexahydrate | 5% w/v |
Each 400ml contains :
11.9g calcium (provided by calcium gluconate and calcium borogluconate)
1.85g magnesium (provided by magnesium hypophosphite).
Also contains 6.84% w/v boric acid.
Excipients:
For a full list of excipients, see section 6.1
6.1 List of excipients
Sodium Bicarbonate 10% or Boric Acid 5%
Water for Injections
Pharmaceutical form
Solution for Injection A clear pale yellow solution
Pharmacological properties
Pharmacotherapeutic group: Mineral Supplements, Calcium, Calcium, combinations with other drugs
ATC Vet Code: QA12AX
5.1 Pharmacodynamic properties
Calcium Borogluconate and Magnesium Hypophosphite are soluble salts of calcium and magnesium respectively used extensively in fluid infusions in correction of metabolic disturbances. On parenteral administration they rapidly increase plasma concentrations of calcium, magnesium and phosphorus. This is effective in the treatment of hypocalcaemia with associated magnesium and phosphorus deficiencies.
Target species
Cattle
Indications
Indicated in the treatment of hypocalcaemia in cattle where increased blood magnesium levels are required.
Dosage
Administer by subcutaneous or slow intravenous injection
Cattle: 200 to 400 ml
Contraindications
None
Adverse reactions
Occasional temporary swelling may occur at sites of subcutaneous administration.
Warnings
i. Special precautions for use in animals
The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly in order to avoid possible neuromuscular dysfunction and cardiac insufficiency. Normal aseptic precautions should be observed.
Sites of subcutaneous administration should be massaged gently.
ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals
Care should be taken to avoid accidental self-injection: may cause irritation at site of injection.
Use during pregnancy, lactation or lay
Safe for use during pregnancy and lactation
Interactions
None
Overdose
Not applicable.
Special warnings
None
Withdrawal period
Cattle
Meat : Zero Days
Milk : Zero Hours
Incompatibilities
None known
Immediate packaging
Marketed in either 400 ml Amber Type III glass vials sealed using black rubber wads and aluminium screw caps, or 400ml polypropylene containers sealed with bromobutyl bungs and aluminium caps.
Storage
Do not store above 25oC. Protect from light.
The product does not contain an antimicrobial preservative. The product is intended for single use only. Any product remaining in the bottle after withdrawal of the required dose should be discarded.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale; Glass bottles: 2 years Polypropylene vials: 18 months
Disposal of unused product
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Additional information
Vm 02000/4125
9 DATE OF FIRST AUTHORISATION
5th July 1994
10 DATE OF REVISION OF THE TEXT
July 2010
Registration holder
Norbrook Laboratories Limited
Station Works
Camlough Road
NEWRY
Co. Down, BT35 6JP
Northern Ireland
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32